CEL-SCI Corp Share Price Today: Live Updates & Key Insights

CEL-SCI Corp share price today is $3.44, up -6.01%. The stock opened at $3.71 against the previous close of $3.66, with an intraday high of $3.71 and low of $3.44.

CEL-SCI Corp Share Price Chart

CEL-SCI Corp

us-stock
To Invest in {{usstockname}}
us-stock

CEL-SCI Corp Share Price Performance

$3.44 -0.0601(-6.01%) CVM at 23 Mar 2026 12:37 PM Biotechnology
Lowest Today 3.44
Highest Today 3.71
Today’s Open 3.71
Prev. Close 3.66
52 Week High 13.48
52 Week Low 1.98
Day’s Range: Low 3.44 High 3.71
52-Week Range: Low 1.98 High 13.48
1 day return -
1 Week return -3.07
1 month return -20.22
3 month return -23.9
6 month return -61.61
1 year return +1151.35
3 year return +56.3
5 year return -80.23
10 year return -

CEL-SCI Corp Institutional Holdings

CEL-SCI Corp Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

CEL-SCI Corp Fundamentals

Market Cap 29.10 M

PB Ratio 2.7792

PE Ratio 0.0

Enterprise Value 33.78 M

Total Assets 28.16 M

Volume 33133

CEL-SCI Corp Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M

Annual Profit FY25:-3885153 -3.9M, FY24:-3969183 -4.0M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M

Annual Net worth FY25:-25411055 -25.4M, FY24:-26920465 -26.9M, FY23:-32194303 -32.2M, FY22:-38267691 -38.3M, FY21:-39187563 -39.2M

Quarterly Revenue Q4/2025:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q4/2024:0 0.0M

Quarterly Profit Q4/2025:-964422 -1.0M, Q3/2025:-960850 -1.0M, Q2/2025:-959009 -1.0M, Q1/2025:-970102 -1.0M, Q4/2024:-991580 -1.0M

Quarterly Net worth Q4/2025:-5469446 -5.5M, Q3/2025:-6100900 -6.1M, Q2/2025:-5664704 -5.7M, Q1/2025:-6572389 -6.6M, Q4/2024:-7073062 -7.1M

About CEL-SCI Corp & investment objective

Company Information CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

Organisation Biotechnology

Employees 0

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

CEL-SCI Corp FAQs

What is the share price of CEL-SCI Corp today?

The current share price of CEL-SCI Corp is $3.44.

Can I buy CEL-SCI Corp shares in India?

Yes, Indian investors can buy CEL-SCI Corp shares by opening an international trading and demat account with Motilal Oswal.

How to buy CEL-SCI Corp shares in India?

You can easily invest in CEL-SCI Corp shares from India by:

Can I buy fractional shares of CEL-SCI Corp?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of CEL-SCI Corp?

CEL-SCI Corp has a market cap of $29.10 M.

In which sector does CEL-SCI Corp belong?

CEL-SCI Corp operates in the Biotechnology sector.

What documents are required to invest in CEL-SCI Corp stocks?

To invest, you typically need:

What is the PE and PB ratio of CEL-SCI Corp?

The PE ratio of CEL-SCI Corp is N/A and the PB ratio is 2.78.